HEADER SIGNALING PROTEIN/INHIBITOR 09-DEC-14 4X6S TITLE GRB7 SH2 DOMAIN WITH PHOSPHOTYROSINE MIMETIC INHIBITOR PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SH2 DOMAIN CONTAINING RESIDUES 423-529; COMPND 5 SYNONYM: B47,EPIDERMAL GROWTH FACTOR RECEPTOR GRB-7,GRB7 ADAPTER COMPND 6 PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PHOSPHOTYROSINE MIMETIC INHIBITOR PEPTIDE G7-TEM1; COMPND 10 CHAIN: L, M; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRB7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS SRC HOMOLOGY DOMAIN, INHIBITOR, PHOSPHOTYROSINE BINDING POCKET, KEYWDS 2 SIGNALING PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.M.WATSON,S.PANJIKAR,M.C.WILCE,J.A.WILCE REVDAT 2 28-OCT-15 4X6S 1 JRNL REVDAT 1 23-SEP-15 4X6S 0 JRNL AUTH G.M.WATSON,M.J.GUNZBURG,N.D.AMBAYE,W.A.LUCAS,D.A.TRAORE, JRNL AUTH 2 K.KULKARNI,K.M.CERGOL,R.J.PAYNE,S.PANJIKAR,S.C.PERO, JRNL AUTH 3 P.PERLMUTTER,M.C.WILCE,J.A.WILCE JRNL TITL CYCLIC PEPTIDES INCORPORATING PHOSPHOTYROSINE MIMETICS AS JRNL TITL 2 POTENT AND SPECIFIC INHIBITORS OF THE GRB7 BREAST CANCER JRNL TITL 3 TARGET. JRNL REF J.MED.CHEM. V. 58 7707 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26359549 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00609 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 9992 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 479 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.2175 - 3.6775 0.98 3260 151 0.1748 0.2070 REMARK 3 2 3.6775 - 2.9192 0.99 3136 165 0.2295 0.2977 REMARK 3 3 2.9192 - 2.5502 1.00 3117 163 0.2461 0.2914 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 1908 REMARK 3 ANGLE : 1.188 2569 REMARK 3 CHIRALITY : 0.047 279 REMARK 3 PLANARITY : 0.006 334 REMARK 3 DIHEDRAL : 13.352 661 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4X6S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000204642. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10038 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 43.218 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 8.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M HEPES PH 7.0, 1% TRYPTONE, 12% REMARK 280 PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.74000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.51900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.44750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.51900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.74000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.44750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 423 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 425 CG1 CG2 CD1 REMARK 470 ARG A 427 CG CD NE CZ NH1 NH2 REMARK 470 THR A 428 OG1 CG2 REMARK 470 LEU A 430 CG CD1 CD2 REMARK 470 ARG A 435 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 439 CG CD OE1 OE2 REMARK 470 GLU A 459 CG CD OE1 OE2 REMARK 470 GLN A 461 CG CD OE1 NE2 REMARK 470 ARG A 462 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 476 CG CD CE NZ REMARK 470 LYS A 478 CG CD CE NZ REMARK 470 ARG A 529 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 425 CG1 CG2 CD1 REMARK 470 ARG B 435 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 439 CG CD OE1 OE2 REMARK 470 ARG B 443 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 447 CG CD OE1 NE2 REMARK 470 GLN B 461 CG CD OE1 NE2 REMARK 470 ARG B 462 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 465 CG CD OE1 NE2 REMARK 470 LYS B 476 CG CD CE NZ REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 ARG B 529 CG CD NE CZ NH1 NH2 REMARK 470 GLU M 3 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1PA L 5 CA - C - N ANGL. DEV. = 24.3 DEGREES REMARK 500 1PA L 5 O - C - N ANGL. DEV. = -22.1 DEGREES REMARK 500 ASP L 6 C - N - CA ANGL. DEV. = 20.1 DEGREES REMARK 500 GLY M 4 O - C - N ANGL. DEV. = -15.5 DEGREES REMARK 500 1PA M 5 C - N - CA ANGL. DEV. = 24.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 1PA M 5 -10.92 REMARK 500 REMARK 500 REMARK: NULL DBREF 4X6S A 423 529 UNP Q14451 GRB7_HUMAN 423 529 DBREF 4X6S B 423 529 UNP Q14451 GRB7_HUMAN 423 529 DBREF 4X6S L 1 11 PDB 4X6S 4X6S 1 11 DBREF 4X6S M 1 11 PDB 4X6S 4X6S 1 11 SEQRES 1 A 107 ALA ALA ILE HIS ARG THR GLN LEU TRP PHE HIS GLY ARG SEQRES 2 A 107 ILE SER ARG GLU GLU SER GLN ARG LEU ILE GLY GLN GLN SEQRES 3 A 107 GLY LEU VAL ASP GLY LEU PHE LEU VAL ARG GLU SER GLN SEQRES 4 A 107 ARG ASN PRO GLN GLY PHE VAL LEU SER LEU CYS HIS LEU SEQRES 5 A 107 GLN LYS VAL LYS HIS TYR LEU ILE LEU PRO SER GLU GLU SEQRES 6 A 107 GLU GLY ARG LEU TYR PHE SER MET ASP ASP GLY GLN THR SEQRES 7 A 107 ARG PHE THR ASP LEU LEU GLN LEU VAL GLU PHE HIS GLN SEQRES 8 A 107 LEU ASN ARG GLY ILE LEU PRO CYS LEU LEU ARG HIS CYS SEQRES 9 A 107 CYS THR ARG SEQRES 1 B 107 ALA ALA ILE HIS ARG THR GLN LEU TRP PHE HIS GLY ARG SEQRES 2 B 107 ILE SER ARG GLU GLU SER GLN ARG LEU ILE GLY GLN GLN SEQRES 3 B 107 GLY LEU VAL ASP GLY LEU PHE LEU VAL ARG GLU SER GLN SEQRES 4 B 107 ARG ASN PRO GLN GLY PHE VAL LEU SER LEU CYS HIS LEU SEQRES 5 B 107 GLN LYS VAL LYS HIS TYR LEU ILE LEU PRO SER GLU GLU SEQRES 6 B 107 GLU GLY ARG LEU TYR PHE SER MET ASP ASP GLY GLN THR SEQRES 7 B 107 ARG PHE THR ASP LEU LEU GLN LEU VAL GLU PHE HIS GLN SEQRES 8 B 107 LEU ASN ARG GLY ILE LEU PRO CYS LEU LEU ARG HIS CYS SEQRES 9 B 107 CYS THR ARG SEQRES 1 L 11 TRP PHE GLU GLY 1PA ASP ASN THR PHE PRO 48V SEQRES 1 M 11 TRP PHE GLU GLY 1PA ASP ASN THR PHE PRO 48V HET 1PA L 5 15 HET 48V L 11 10 HET 1PA M 5 15 HET 48V M 11 10 HETNAM 1PA 4-(CARBOXYMETHYL)-L-PHENYLALANINE HETNAM 48V {[(2R)-2,3-DIAMINO-3-OXOPROPYL]SULFANYL}ACETIC ACID HETSYN 1PA P-(CARBOXYMETHYL)PHENYLALANINE FORMUL 3 1PA 2(C11 H13 N O4) FORMUL 3 48V 2(C5 H10 N2 O3 S) FORMUL 5 HOH *29(H2 O) HELIX 1 AA1 SER A 437 GLN A 447 1 11 HELIX 2 AA2 ASP A 504 ASN A 515 1 12 HELIX 3 AA3 SER B 437 GLN B 447 1 11 HELIX 4 AA4 ASP B 504 ASN B 515 1 12 SHEET 1 AA1 6 ARG A 501 PHE A 502 0 SHEET 2 AA1 6 ARG A 490 SER A 494 -1 N PHE A 493 O PHE A 502 SHEET 3 AA1 6 LYS A 476 GLU A 487 -1 N LEU A 483 O SER A 494 SHEET 4 AA1 6 PHE A 467 HIS A 473 -1 N LEU A 471 O LYS A 478 SHEET 5 AA1 6 LEU A 454 GLU A 459 -1 N ARG A 458 O VAL A 468 SHEET 6 AA1 6 HIS A 525 CYS A 526 1 O HIS A 525 N PHE A 455 SHEET 1 AA2 6 ARG B 501 PHE B 502 0 SHEET 2 AA2 6 ARG B 490 SER B 494 -1 N PHE B 493 O PHE B 502 SHEET 3 AA2 6 LYS B 476 GLU B 487 -1 N LEU B 483 O SER B 494 SHEET 4 AA2 6 PHE B 467 HIS B 473 -1 N PHE B 467 O ILE B 482 SHEET 5 AA2 6 LEU B 454 GLU B 459 -1 N ARG B 458 O VAL B 468 SHEET 6 AA2 6 HIS B 525 CYS B 526 1 O HIS B 525 N PHE B 455 LINK N TRP L 1 C09 48V L 11 1555 1555 1.34 LINK C GLY L 4 N 1PA L 5 1555 1555 1.27 LINK C 1PA L 5 N ASP L 6 1555 1555 1.27 LINK C PRO L 10 N01 48V L 11 1555 1555 1.34 LINK N TRP M 1 C09 48V M 11 1555 1555 1.32 LINK C GLY M 4 N 1PA M 5 1555 1555 1.26 LINK C 1PA M 5 N ASP M 6 1555 1555 1.28 LINK C PRO M 10 N01 48V M 11 1555 1555 1.33 CRYST1 55.480 68.895 77.038 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018024 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014515 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012981 0.00000